NCT01594866View on ClinicalTrials.gov

Lexapro®'s Efficacy After Dose Escalation in Remission Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

escitalopram

escitalopram 20mg and 30mg p.o. daily, 6 weeks

DRUG

escitalopram

escitalopram 10mg p.o. for 1 week, and escitalopram 20mg p.o. for 3 weeks before randomized to placebo and experimental groups

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01594866 - Lexapro®'s Efficacy After Dose Escalation in Remission Study | Biotech Hunter | Biotech Hunter